Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Daily News

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

Caitlin E. Cox

August 06, 2021

News Opinion Off Script TCT 2019

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

Kwan S. Lee

October 14, 2019

News Daily News

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

Todd Neale

September 21, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

ORBITA Trial

Presenter: Paul S. Teirstein

May 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Conference News ACC 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

Shelley Wood

March 05, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

Top Stories in Cardiology, November 2017

Podcast Heart Sounds

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Advertisement

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

Off Script: PCI of the Future? Let’s Break Down the Border Between Physiology and Anatomy

FFR Values Linked to Quality-of-Life Improvement After PCI in Stable CAD Patients

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

TCTMD’s Top 10 Most Popular Stories for May 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

ORBITA Trial

TCTMD’s Top 10 Most Popular Stories for April 2018

ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last

TCTMD’s Top 10 Most Popular Stories for December 2017

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

TCTMD’s Top 10 Most Popular Stories for November 2017

Top Stories in Cardiology, November 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content